149 related articles for article (PubMed ID: 19483143)
1. COMDECOM: predicting the lifetime of screening compounds in DMSO solution.
Zitha-Bovens E; Maas P; Wife D; Tijhuis J; Hu QN; Kleinöder T; Gasteiger J
J Biomol Screen; 2009 Jun; 14(5):557-65. PubMed ID: 19483143
[TBL] [Abstract][Full Text] [Related]
2. Stability of screening compounds in wet DMSO.
Engeloch C; Schopfer U; Muckenschnabel I; Le Goff F; Mees H; Boesch K; Popov M
J Biomol Screen; 2008 Dec; 13(10):999-1006. PubMed ID: 19029012
[TBL] [Abstract][Full Text] [Related]
3. Overcoming problems of compound storage in DMSO: solvent and process alternatives.
Waybright TJ; Britt JR; McCloud TG
J Biomol Screen; 2009 Jul; 14(6):708-15. PubMed ID: 19531665
[TBL] [Abstract][Full Text] [Related]
4. Biological assay challenges from compound solubility: strategies for bioassay optimization.
Di L; Kerns EH
Drug Discov Today; 2006 May; 11(9-10):446-51. PubMed ID: 16635808
[TBL] [Abstract][Full Text] [Related]
5. Streamlined system for purifying and quantifying a diverse library of compounds and the effect of compound concentration measurements on the accurate interpretation of biological assay results.
Popa-Burke IG; Issakova O; Arroway JD; Bernasconi P; Chen M; Coudurier L; Galasinski S; Jadhav AP; Janzen WP; Lagasca D; Liu D; Lewis RS; Mohney RP; Sepetov N; Sparkman DA; Hodge CN
Anal Chem; 2004 Dec; 76(24):7278-87. PubMed ID: 15595870
[TBL] [Abstract][Full Text] [Related]
6. The effect of freeze/thaw cycles on the stability of compounds in DMSO.
Kozikowski BA; Burt TM; Tirey DA; Williams LE; Kuzmak BR; Stanton DT; Morand KL; Nelson SL
J Biomol Screen; 2003 Apr; 8(2):210-5. PubMed ID: 12844443
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of in silico models for estimating drug preformulation risk in PEG400/water and Tween80/water systems.
Crivori P; Morelli A; Pezzetta D; Rocchetti M; Poggesi I
Eur J Pharm Sci; 2007 Nov; 32(3):169-81. PubMed ID: 17714921
[TBL] [Abstract][Full Text] [Related]
8. The effect of room-temperature storage on the stability of compounds in DMSO.
Kozikowski BA; Burt TM; Tirey DA; Williams LE; Kuzmak BR; Stanton DT; Morand KL; Nelson SL
J Biomol Screen; 2003 Apr; 8(2):205-9. PubMed ID: 12844442
[TBL] [Abstract][Full Text] [Related]
9. A novel approach to determine water content in DMSO for a compound collection repository.
Semin DJ; Malone TJ; Paley MT; Woods PW
J Biomol Screen; 2005 Sep; 10(6):568-72. PubMed ID: 16103417
[TBL] [Abstract][Full Text] [Related]
10. In silico estimation of DMSO solubility of organic compounds for bioscreening.
Balakin KV; Ivanenkov YA; Skorenko AV; Nikolsky YV; Savchuk NP; Ivashchenko AA
J Biomol Screen; 2004 Feb; 9(1):22-31. PubMed ID: 15006145
[TBL] [Abstract][Full Text] [Related]
11. Predicting aqueous solubility from structure.
Delaney JS
Drug Discov Today; 2005 Feb; 10(4):289-95. PubMed ID: 15708748
[TBL] [Abstract][Full Text] [Related]
12. Screening library evolution through automation of solution preparation.
Schopfer U; Höhn F; Hueber M; Girod M; Engeloch C; Popov M; Muckenschnabel I
J Biomol Screen; 2007 Aug; 12(5):724-32. PubMed ID: 17507640
[TBL] [Abstract][Full Text] [Related]
13. In silico approaches to prediction of aqueous and DMSO solubility of drug-like compounds: trends, problems and solutions.
Balakin KV; Savchuk NP; Tetko IV
Curr Med Chem; 2006; 13(2):223-41. PubMed ID: 16472214
[TBL] [Abstract][Full Text] [Related]
14. High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids.
Morissette SL; Almarsson O; Peterson ML; Remenar JF; Read MJ; Lemmo AV; Ellis S; Cima MJ; Gardner CR
Adv Drug Deliv Rev; 2004 Feb; 56(3):275-300. PubMed ID: 14962582
[TBL] [Abstract][Full Text] [Related]
15. Application of a Dried-DMSO rapid throughput 24-h equilibrium solubility in advancing discovery candidates.
Alelyunas YW; Liu R; Pelosi-Kilby L; Shen C
Eur J Pharm Sci; 2009 May; 37(2):172-82. PubMed ID: 19429424
[TBL] [Abstract][Full Text] [Related]
16. QSAR-based solubility model for drug-like compounds.
Gozalbes R; Pineda-Lucena A
Bioorg Med Chem; 2010 Oct; 18(19):7078-84. PubMed ID: 20810286
[TBL] [Abstract][Full Text] [Related]
17. Quality assessment and analysis of Biogen Idec compound library.
Bowes S; Sun D; Kaffashan A; Zeng C; Chuaqui C; Hronowski X; Buko A; Zhang X; Josiah S
J Biomol Screen; 2006 Oct; 11(7):828-35. PubMed ID: 16956997
[TBL] [Abstract][Full Text] [Related]
18. Comparison of nephelometric, UV-spectroscopic, and HPLC methods for high-throughput determination of aqueous drug solubility in microtiter plates.
Hoelke B; Gieringer S; Arlt M; Saal C
Anal Chem; 2009 Apr; 81(8):3165-72. PubMed ID: 19317458
[TBL] [Abstract][Full Text] [Related]
19. High throughput UV method for the estimation of thermodynamic solubility and the determination of the solubility in biorelevant media.
Bard B; Martel S; Carrupt PA
Eur J Pharm Sci; 2008 Mar; 33(3):230-40. PubMed ID: 18207706
[TBL] [Abstract][Full Text] [Related]
20. NanoStore: a concept for logistical improvements of compound handling in high-throughput screening.
Benson N; Boyd HF; Everett JR; Fries J; Gribbon P; Haque N; Henco K; Jessen T; Martin WH; Mathewson TJ; Sharp RE; Spencer RW; Stuhmeier F; Wallace MS; Winkler D
J Biomol Screen; 2005 Sep; 10(6):573-80. PubMed ID: 16103412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
